New potent antibacterial oxazolidinone (MRX-I) with an improved class safety profile

Time:2014-05-13 / View:331 times

Prev: Selection and characterization of Staphylococcus aureus mutants with reduced susceptibility to the investigational oxazolidinone MRX-I

Next: Metabolism of MRX-I, a novel antibacterial oxazolidinone, in humans: the oxidative ring opening of 2,3-dihydropyridin-4-one catalyzed by non-P450 enzymes

Back